Viewing nowBelmetec Tablets 10 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

MFDS item code 201100827 · Notified 2011.02.22 · Insurance code 643305990
Treatment of essential hypertension
Essential hypertension is hypertension that occurs without a specific cause, focusing on controlling blood pressure to normal ranges to prevent cardiovascular complications. This medication significantly lowers blood pressure in essential hypertension, reducing the burden on blood vessels and the heart. By controlling blood pressure, it helps decrease the risks of stroke and myocardial infarction, improving overall cardiovascular health. Effective treatment can be achieved when used consistently along with lifestyle modifications. Therefore, this medication is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If an additional reduction in blood pressure is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the medicine at the same time every day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years and older. No overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use of this medicine is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
<Pediatric patients> The safety and efficacy in children have not been established.
This medication can cause severe harm to the fetus and newborn if taken during the 2nd and 3rd trimesters of pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. Individuals allergic to any ingredients in this medication, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with severe liver impairment, and those with biliary obstruction should not take this medication. Patients with a genetic disorder that prevents lactose digestion should also refrain from taking this medication. Patients with low blood volume or inadequate sodium levels may experience hypotension when beginning this medication, necessitating caution, and appropriate measures should be taken immediately if hypotension occurs during treatment. Patients with severe heart failure or very poor kidney function may see worsening kidney function from taking this medication, so regular blood tests are necessary. Due to its blood pressure-lowering effects, dizziness may occur, so driving or operating dangerous machinery is not advised. This medication may pose a risk of hyperkalemia; potassium levels should be monitored regularly, and extra caution is required if taking potassium supplements or potassium-sparing diuretics. When taken alongside other antihypertensives, blood pressure may drop too low; therefore, it should be taken according to a physician's instructions. Co-administration of lithium preparations with this medication can dangerously elevate lithium levels; hence, their combined use should be avoided. Taking this medication alongside non-steroidal anti-inflammatory drugs may risk kidney function deterioration, so adequate hydration and regular monitoring of renal function are necessary. This medication may rarely cause gastrointestinal issues such as chronic diarrhea with long-term use; if any abnormal symptoms appear, consult a physician. If symptoms such as skin rashes, itching, or swelling of the face or neck occur during treatment, inform healthcare personnel immediately. Pregnant women taking this medication risk severe complications for the fetus, so those planning to become pregnant or currently pregnant should definitely consult healthcare personnel. Breastfeeding women are advised to either stop breastfeeding or discontinue this medication as it may pass into breast milk. Safety and efficacy in pediatric patients have not been sufficiently established, so it is recommended that children do not take this medication. Elderly patients may have higher concentrations of this medication in their system, so caution is necessary when administering it. Overdose may cause hypotension or heart rhythm disturbances, and immediate medical assistance is required. This medication is known to have a low risk of carcinogenicity even with long-term use; however, any abnormal symptoms during treatment should be discussed with a healthcare provider.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 25 degrees Celsius. Proper storage helps maintain the medication's efficacy and safety.
White round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.